MedPath

The effect of a Vaj (Acorus calamus) syrup on Alzheimer's

Phase 2
Conditions
Alzheimer.
Other degenerative disorders of nervous system in diseases classified elsewhere
Registration Number
IRCT2017102030776N2
Lead Sponsor
Traditional Medicine and History Research Center of Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

aged over 50 years? CDR score less than or equal to 2? ADAS-COG score greater than or equal to 12? no heart disease? no high blood pressure? no drug abuse and alcohol dependency?Non use of anticoagulants? no diabetes -ability to participate in the study? no more than 80 years old? definite Alzheimer's disease
Outcome criteria : bipolar disorder ??? mild to severe depression ? co-morbidity with other neurological diseases ? inability to participate in the study? Inability to continue treatment ? causing side effects

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Alzheimer. Timepoint: four, eight, twelve weeks after intervention. Method of measurement: CDR and ADAS-COG questionnaire.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: four, eight, twelve weeks after intervention. Method of measurement: Self-made questionnaire.
© Copyright 2025. All Rights Reserved by MedPath